Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$10.1M Sell
25,500
-19,200
-43% -$5.47M 0.01% 816
2026
Q1
$7.75M Buy
44,700
+28,000
+168% +$5.74M 0.01% 895
2025
Q4
$4.28M Sell
16,700
-11,900
-42% -$3.12M 0.01% 1245
2025
Q3
$7.44M Buy
28,600
+7,100
+33% +$1.87M 0.01% 935
2025
Q2
$5.26M Buy
21,500
+18,900
+727% +$4.71M 0.01% 1063
2025
Q1
$688K Sell
2,600
-81,000
-97% -$21.9M ﹤0.01% 2080
2024
Q4
$21.2M Buy
83,600
+56,100
+204% +$15M 0.08% 147
2024
Q3
$8.71M Buy
27,500
+13,600
+98% +$4.84M 0.03% 467
2024
Q2
$5.19M Sell
13,900
-36,500
-72% -$12.3M 0.03% 647
2024
Q1
$17.5M Buy
50,400
+38,000
+306% +$14.4M 0.11% 172
2023
Q4
$5.68M Buy
12,400
+11,200
+933% +$5.52M 0.05% 575
2023
Q3
$584K Sell
1,200
-2,300
-66% -$1.08M 0.01% 1603
2023
Q2
$1.56M Buy
+3,500
New +$1.76M 0.02% 1033
2023
Q1
Sell
-1,600
Closed -$819K 2659
2022
Q4
$819K Buy
+1,600
New +$841K 0.02% 1248
2022
Q1
Sell
-1,900
Closed -$880K 2301
2021
Q4
$880K Sell
1,900
-1,400
-42% -$620K 0.01% 1089
2021
Q3
$1.29M Buy
+3,300
New +$1.4M 0.02% 978

Other funds holding HUM

Paul Tudor Jones's HUM Position: Q2 2026 in Review

Paul Tudor Jones increased its Humana (HUM) stake by 71% in Q2 2026, buying an estimated $4.45M and bringing the position to 37,563 shares worth $14.9M. The position accounts for 0.02% of the portfolio, ranked #619.

Paul Tudor Jones first reported a position in HUM in Q2 2013 and has held it in 33 quarters since. The position peaked at $54.9M in Q1 2024. 919 funds tracked by Wall St. Rank hold HUM as of Q2 2026.

  • Paul Tudor Jones held 37,563 shares of Humana worth $14.9M as of Q2 2026.
  • Paul Tudor Jones bought 15,638 Humana shares in Q2 2026, an estimated $4.45M.
  • Humana made up 0.02% of Paul Tudor Jones's portfolio in Q2 2026, its #619 holding.
  • Paul Tudor Jones first reported a position in Humana in Q2 2013 and has held it in 33 quarters since.
  • Paul Tudor Jones's Humana position peaked at $54.9M in Q1 2024.
  • 919 funds tracked by Wall St. Rank held Humana as of Q2 2026.

Based on Tudor Investment Corp's 13F filing for Q2 2026, filed 14 Aug 2026.